Diego Bertoli

499 total citations
24 papers, 254 citations indexed

About

Diego Bertoli is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Diego Bertoli has authored 24 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Diego Bertoli's work include Acute Myeloid Leukemia Research (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and Immune Cell Function and Interaction (4 papers). Diego Bertoli is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and Immune Cell Function and Interaction (4 papers). Diego Bertoli collaborates with scholars based in Italy, United States and United Kingdom. Diego Bertoli's co-authors include Luisa Imberti, Marco Chiarini, Federico Serana, Luigi Caimi, Alessandra Sottini, Cinzia Zanotti, Ruggero Capra, Alessandra Sottini, Andrea Bosio and Simonetta Gerevini and has published in prestigious journals such as Blood, PLoS ONE and Brain.

In The Last Decade

Diego Bertoli

21 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego Bertoli Italy 9 126 52 52 48 37 24 254
Amichai Schattner Israel 7 110 0.9× 38 0.7× 34 0.7× 49 1.0× 30 0.8× 17 278
Judith Bauer Germany 4 216 1.7× 33 0.6× 31 0.6× 54 1.1× 15 0.4× 4 345
Caroline Dudreuilh United Kingdom 8 90 0.7× 21 0.4× 71 1.4× 33 0.7× 21 0.6× 17 230
Iwona Auer-Grzesiak Canada 6 163 1.3× 89 1.7× 81 1.6× 36 0.8× 15 0.4× 7 342
Agnieszka Tomaszewska Poland 8 53 0.4× 52 1.0× 38 0.7× 35 0.7× 11 0.3× 27 194
Arthur Lynch United States 2 83 0.7× 72 1.4× 84 1.6× 52 1.1× 35 0.9× 5 252
Jong‐Mi Lee South Korea 9 77 0.6× 27 0.5× 44 0.8× 55 1.1× 13 0.4× 30 246
Hector A. DePaz United States 10 237 1.9× 43 0.8× 58 1.1× 49 1.0× 36 1.0× 36 397
Samuel Fan United States 6 271 2.2× 26 0.5× 108 2.1× 59 1.2× 37 1.0× 7 412
Malin Ryner Sweden 8 104 0.8× 125 2.4× 54 1.0× 27 0.6× 17 0.5× 11 247

Countries citing papers authored by Diego Bertoli

Since Specialization
Citations

This map shows the geographic impact of Diego Bertoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Bertoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Bertoli more than expected).

Fields of papers citing papers by Diego Bertoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Bertoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Bertoli. The network helps show where Diego Bertoli may publish in the future.

Co-authorship network of co-authors of Diego Bertoli

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Bertoli. A scholar is included among the top collaborators of Diego Bertoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Bertoli. Diego Bertoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quaresima, Virginia, Andrea Pilotto, Diego Bertoli, et al.. (2024). Plasma p-tau181 and amyloid markers in Alzheimer’s disease: A comparison between Lumipulse and SIMOA. Neurobiology of Aging. 143. 30–40. 7 indexed citations
2.
Quaresima, Virginia, Andrea Pilotto, Diego Bertoli, et al.. (2024). Plasma P-Tau181 and Amyloid Markers in Alzheimer's Disease: A Method Comparison between Simoa and Lumipulse. SSRN Electronic Journal. 1 indexed citations
3.
Pilotto, Andrea, Virginia Quaresima, Diego Bertoli, et al.. (2024). Plasma p-tau217 in Alzheimer’s disease: Lumipulse and ALZpath SIMOA head-to-head comparison. Brain. 148(2). 408–415. 17 indexed citations
5.
Bertoli, Diego, Chiara Cattaneo, Camillo Almici, et al.. (2022). The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation. Annals of Hematology. 101(6). 1227–1237. 11 indexed citations
6.
Borlenghi, Erika, Chiara Cattaneo, Diego Bertoli, et al.. (2022). Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up—A Single Center Experience. Cancers. 14(19). 4716–4716. 4 indexed citations
7.
Giustini, Viviana, Alessandra Sottini, Diego Bertoli, et al.. (2021). Cryptococcal-related meningoencephalitis in a patient with sarcoidosis and CD4 lymphocytopenia: thorough immunological characterization of lymphocyte homeostasis. Journal of Neurosurgical Sciences. 65(2). 207–210.
8.
Chiarini, Marco, Ruggero Capra, Federico Serana, et al.. (2020). Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients. Journal of Translational Medicine. 18(1). 169–169. 5 indexed citations
11.
Bertoli, Diego, Alessandra Sottini, Ruggero Capra, et al.. (2019). Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy. Scientific Reports. 9(1). 16605–16605. 5 indexed citations
12.
Gerevini, Simonetta, Ruggero Capra, Diego Bertoli, Alessandra Sottini, & Luisa Imberti. (2019). Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy. Multiple Sclerosis Journal. 25(8). 1196–1201. 29 indexed citations
14.
Bertoli, Diego, Alessandro Re, Marco Chiarini, et al.. (2016). B- and T-lymphocyte number and function in HIV+/HIV− lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation. Scientific Reports. 6(1). 37995–37995. 3 indexed citations
15.
Imberti, Luisa, Mirko Scarsi, Cinzia Zanotti, et al.. (2015). Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients. Journal of Translational Medicine. 13(1). 12–12. 17 indexed citations
17.
Serana, Federico, Marco Chiarini, Alessandra Sottini, et al.. (2014). Immunological biomarkers identifying natalizumab-treated multiple sclerosis patients at risk of progressive multifocal leukoencephalopathy. Journal of Neuroimmunology. 277(1-2). 6–12. 5 indexed citations
18.
Sottini, Alessandra, Arnalda Lanfranchi, Federico Serana, et al.. (2014). Long-Lasting Production of New T and B Cells and T-Cell Repertoire Diversity in Patients with Primary Immunodeficiency Who Had Undergone Stem Cell Transplantation: A Single-Centre Experience. Journal of Immunology Research. 2014. 1–10. 1 indexed citations
19.
Sottini, Alessandra, et al.. (2014). Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR. Journal of Visualized Experiments. 29 indexed citations
20.
Serana, Federico, Marco Chiarini, Eugenia Quirós-Roldán, et al.. (2014). Modulation of Regulatory T-Cell Subsets in Very Long-Term Treated Aviremic HIV+ Patients and Untreated Viremic Patients. The Open AIDS Journal. 8(1). 1–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026